PortfoliosLab logoPortfoliosLab logo
NBIX vs. NFLX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NBIX vs. NFLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neurocrine Biosciences, Inc. (NBIX) and Netflix, Inc. (NFLX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NBIX achieves a 24.87% return, which is significantly higher than NFLX's -21.75% return. Over the past 10 years, NBIX has underperformed NFLX with an annualized return of 13.85%, while NFLX has yielded a comparatively higher 22.56% annualized return.


NBIX

1D
-1.91%
1M
8.85%
6M
30.43%
YTD
24.87%
1Y
32.71%
3Y*
21.73%
5Y*
12.33%
10Y*
13.85%

NFLX

1D
-2.78%
1M
-9.72%
6M
-17.99%
YTD
-21.75%
1Y
-41.07%
3Y*
18.56%
5Y*
6.48%
10Y*
22.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NBIX vs. NFLX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NBIX
Neurocrine Biosciences, Inc.
24.87%3.90%3.60%10.31%40.24%-11.14%-10.83%50.53%-7.96%100.49%
NFLX
Netflix, Inc.
-21.75%5.19%83.07%65.11%-51.05%11.41%67.11%20.89%39.44%55.06%

Correlation

The correlation between NBIX and NFLX is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since May 23, 2002

0.22

Over the past year, the correlation between NBIX and NFLX has dropped to 0.01 - well below their long-term average of 0.22, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

NBIX:

$17.81B

NFLX:

$308.95B

EPS

NBIX:

$6.50

NFLX:

$3.10

PE Ratio

NBIX:

27.23

NFLX:

23.69

PEG Ratio

NBIX:

0.54

NFLX:

0.94

PS Ratio

NBIX:

5.87

NFLX:

6.76

PB Ratio

NBIX:

5.37

NFLX:

10.13

Total Revenue (TTM)

NBIX:

$3.10B

NFLX:

$46.89B

Gross Profit (TTM)

NBIX:

$3.05B

NFLX:

$22.99B

EBITDA (TTM)

NBIX:

$881.20M

NFLX:

$26.91B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NBIX vs. NFLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBIX
NBIX Risk / Return Rank: 7373
Overall Rank
NBIX Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
NBIX Sortino Ratio Rank: 7171
Sortino Ratio Rank
NBIX Omega Ratio Rank: 7171
Omega Ratio Rank
NBIX Calmar Ratio Rank: 7373
Calmar Ratio Rank
NBIX Martin Ratio Rank: 7272
Martin Ratio Rank

NFLX
NFLX Risk / Return Rank: 44
Overall Rank
NFLX Sharpe Ratio Rank: 22
Sharpe Ratio Rank
NFLX Sortino Ratio Rank: 44
Sortino Ratio Rank
NFLX Omega Ratio Rank: 44
Omega Ratio Rank
NFLX Calmar Ratio Rank: 55
Calmar Ratio Rank
NFLX Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NBIX vs. NFLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Netflix, Inc. (NFLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NBIXNFLXDifference
Sharpe ratioReturn per unit of total volatility

+2.20

Sortino ratioReturn per unit of downside risk

+3.33

Omega ratioGain probability vs. loss probability

1.20

0.77

+0.43

Calmar ratioReturn relative to maximum drawdown

1.50

-0.93

+2.44

Martin ratioReturn relative to average drawdown

3.29

-1.67

+4.97

NBIX vs. NFLX - Sharpe Ratio Comparison

The current NBIX Sharpe Ratio is 0.99, which is higher than the NFLX Sharpe Ratio of -1.21. The chart below compares the historical Sharpe Ratios of NBIX and NFLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NBIX vs. NFLX - Drawdown Comparison

The maximum NBIX drawdown since its inception was -97.21%, which is greater than NFLX's maximum drawdown of -81.99%. Use the drawdown chart below to compare losses from any high point for NBIX and NFLX.


Loading charts...

Drawdown Indicators


NBIXNFLXDifference

Max Drawdown

Largest peak-to-trough decline

-97.21%

-81.99%

-15.22%

Max Drawdown (1Y)

Largest decline over 1 year

-20.90%

-44.36%

+23.46%

Max Drawdown (3Y)

Largest decline over 3 years

-42.89%

-47.06%

+4.17%

Max Drawdown (5Y)

Largest decline over 5 years

-42.89%

-75.95%

+33.06%

Max Drawdown (10Y)

Largest decline over 10 years

-46.39%

-75.95%

+29.56%

Current Drawdown

Current decline from peak

-1.91%

-45.21%

+43.30%

Average Drawdown

Average peak-to-trough decline

-43.74%

-24.96%

-18.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.52%

24.72%

-15.20%

Volatility

NBIX vs. NFLX - Volatility Comparison

The current volatility for Neurocrine Biosciences, Inc. (NBIX) is 8.08%, while Netflix, Inc. (NFLX) has a volatility of 11.87%. This indicates that NBIX experiences smaller price fluctuations and is considered to be less risky than NFLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NBIXNFLXDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.08%

11.87%

-3.79%

Volatility (6M)

Calculated over the trailing 6-month period

23.42%

26.83%

-3.41%

Volatility (1Y)

Calculated over the trailing 1-year period

31.73%

34.48%

-2.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.83%

43.37%

-10.54%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.03%

41.52%

-2.49%

Dividends

NBIX vs. NFLX - Dividend Comparison

Neither NBIX nor NFLX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NBIX vs. NFLX - Financials Comparison

This section allows you to compare key financial metrics between Neurocrine Biosciences, Inc. and Netflix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
814.50M
12.25B
(NBIX) Total Revenue
(NFLX) Total Revenue
Values in USD except per share items

NBIX vs. NFLX - Profitability Comparison

The chart below illustrates the profitability comparison between Neurocrine Biosciences, Inc. and Netflix, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
98.3%
51.9%
Portfolio components
NBIX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.

NFLX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Netflix, Inc. reported a gross profit of 6.36B and revenue of 12.25B. Therefore, the gross margin over that period was 51.9%.

NBIX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.

NFLX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Netflix, Inc. reported an operating income of 3.96B and revenue of 12.25B, resulting in an operating margin of 32.3%.

NBIX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.

NFLX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Netflix, Inc. reported a net income of 5.28B and revenue of 12.25B, resulting in a net margin of 43.1%.


Frequently Asked Questions


NBIX and NFLX have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NFLX has higher volatility (11.87%) compared to NBIX (8.08%). In terms of maximum drawdown, NBIX dropped -97.21% vs NFLX's -81.99%.

NBIX currently has the higher Sharpe Ratio (0.99 vs -1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NBIX and NFLX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer